跳至主要内容
临床试验/IRCT20240309061224N1
IRCT20240309061224N1招募中3 期

Efficacy of risperidone/ NAC versus risperidone on cognitive functioning over the three months of treatment for psychotic disorder: a double-blind randomized clinical trial

Zanjan University of Medical Sciences0 个研究点目标入组 38 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Filling out the consent form by the patient's guardian and having consent for the patient to enter the research project
  • Being in the category of psychotic diseases : Participants had to meet criteria for a DSM-V psychotic disorder, including schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, depression with psychosis, substance-induced psychotic disorder.
  • The patient is not dangerous and does not pose a danger to herself or others

排除标准

  • Dissatisfaction : Lack of consent, not filling out the consent form by the patient's guardian and not having consent for the patient to enter the research project
  • Being dangerous to yourself or others: The dangerousness of the patient and the high probability of having a risk of life and injury to oneself and others

研究者

相似试验